China Cord Blood PE Ratio 2010-2022 | CORBF
Current and historical p/e ratio for China Cord Blood (CORBF) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. China Cord Blood PE ratio as of May 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| China Cord Blood PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-19 | 1.05 | 1.64 | |
| 2022-03-31 | 3.85 | $0.64 | 6.02 |
| 2021-12-31 | 4.19 | $0.66 | 6.35 |
| 2021-09-30 | 4.67 | $0.64 | 7.30 |
| 2021-06-30 | 5.34 | $0.64 | 8.34 |
| 2021-03-31 | 4.53 | $0.62 | 7.31 |
| 2020-12-31 | 3.71 | $0.57 | 6.51 |
| 2020-09-30 | 3.54 | $0.59 | 6.00 |
| 2020-06-30 | 3.10 | $0.57 | 5.44 |
| 2020-03-31 | 3.18 | $0.55 | 5.78 |
| 2019-12-31 | 5.00 | $0.55 | 9.09 |
| 2019-09-30 | 4.84 | $0.45 | 10.76 |
| 2019-06-30 | 5.78 | $0.39 | 14.82 |
| 2019-03-31 | 7.02 | $0.35 | 20.06 |
| 2018-12-31 | 6.45 | $0.28 | 23.04 |
| 2018-09-30 | 6.99 | $0.30 | 23.30 |
| 2018-06-30 | 9.40 | $0.31 | 30.31 |
| 2018-03-31 | 10.10 | $0.31 | 32.58 |
| 2017-12-31 | 9.85 | $0.34 | 28.98 |
| 2017-09-30 | 11.01 | $0.35 | 31.46 |
| 2017-06-30 | 9.39 | $0.29 | 32.37 |
| 2017-03-31 | 6.59 | $0.23 | 28.67 |
| 2016-12-31 | 6.06 | $0.19 | 31.89 |
| 2016-09-30 | 5.06 | $0.19 | 26.63 |
| 2016-06-30 | 5.69 | $0.20 | 28.47 |
| 2016-03-31 | 6.01 | $0.20 | 30.05 |
| 2015-12-31 | 6.31 | $0.17 | 37.10 |
| 2015-09-30 | 5.96 | $0.07 | 85.15 |
| 2015-06-30 | 6.10 | $0.09 | 67.77 |
| 2015-03-31 | 5.06 | $0.12 | 42.16 |
| 2014-12-31 | 4.48 | $0.19 | 23.55 |
| 2014-09-30 | 4.84 | $0.26 | 18.62 |
| 2014-06-30 | 5.47 | $0.25 | 21.86 |
| 2014-03-31 | 3.96 | $0.26 | 15.23 |
| 2013-12-31 | 3.97 | $0.24 | 16.54 |
| 2013-09-30 | 3.76 | $0.24 | 15.68 |
| 2013-06-30 | 2.78 | $0.24 | 11.59 |
| 2013-03-31 | 2.90 | $0.23 | 12.61 |
| 2012-12-31 | 2.58 | $0.24 | 10.77 |
| 2012-09-30 | 2.67 | $0.26 | 10.28 |
| 2012-06-30 | 2.51 | $0.26 | 9.63 |
| 2012-03-31 | 2.81 | $0.28 | 10.04 |
| 2011-12-31 | 2.62 | $0.27 | 9.72 |
| 2011-09-30 | 2.98 | $0.24 | 12.42 |
| 2011-06-30 | 3.22 | $0.24 | 13.41 |
| 2011-03-31 | 3.23 | $0.20 | 16.14 |
| 2010-12-31 | 3.98 | $0.18 | 22.11 |
| 2010-09-30 | 5.25 | $0.16 | 32.80 |
| 2010-06-30 | 5.20 | $0.15 | 34.65 |
| 2010-03-31 | 5.94 | $0.15 | 39.60 |
| 2009-12-31 | 6.44 | $0.07 | 91.94 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.000B |
| Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.565B | 26.36 |
| Elevance Health (ELV) | United States | $91.235B | 11.77 |
| CVS Health (CVS) | United States | $79.418B | 9.87 |
| Cencora (COR) | United States | $56.719B | 19.73 |
| DiDi Global (DIDIY) | China | $21.932B | 33.29 |
| Natera (NTRA) | United States | $20.928B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $13.109B | 13.88 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.943B | 0.00 |
| CochLear (CHEOY) | Australia | $11.734B | 0.00 |
| Revvity (RVTY) | United States | $11.115B | 19.13 |
| ICON (ICLR) | Ireland | $10.559B | 9.82 |
| Viatris (VTRS) | United States | $10.281B | 3.53 |
| Doximity (DOCS) | United States | $10.038B | 46.76 |
| Avantor (AVTR) | United States | $9.104B | 13.23 |
| Medpace Holdings (MEDP) | United States | $8.794B | 23.36 |
| HealthEquity (HQY) | United States | $8.442B | 41.53 |
| Sonic Healthcare (SKHHY) | Australia | $8.311B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.944B | 13.61 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.201B | 38.89 |
| Bausch + Lomb (BLCO) | Canada | $4.160B | 24.52 |
| Sotera Health (SHC) | United States | $3.616B | 20.55 |
| Alignment Healthcare (ALHC) | United States | $3.213B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.025B | 39.33 |
| Concentras Parent (CON) | United States | $2.892B | 16.71 |
| Organon (OGN) | United States | $2.340B | 2.49 |
| Ardent Health Partners (ARDT) | United States | $2.167B | 9.24 |
| GeneDx Holdings (WGS) | United States | $2.026B | 78.04 |
| Premier (PINC) | United States | $1.903B | 14.44 |
| Progyny (PGNY) | United States | $1.843B | 40.57 |
| PACS (PACS) | United States | $1.623B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.411B | 28.21 |
| Teladoc Health (TDOC) | United States | $1.282B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.277B | 9.72 |
| Establishment Labs Holdings (ESTA) | $1.065B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.986B | 15.39 |
| Nutex Health (NUTX) | United States | $0.981B | 14.82 |
| Agilon Health (AGL) | United States | $0.969B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.858B | 8.04 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.679B | 4.57 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.38 |
| Auna S.A (AUNA) | Luxembourg | $0.524B | 13.88 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.481B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.404B | 0.00 |
| SBC Medicals (SBC) | United States | $0.353B | 0.00 |
| Oncology Institute (TOI) | United States | $0.231B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.211B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |